Pugashetti, Rupa <br/><br/>
Efalizumab discontinuation: a practical strategy.  [electronic resource] 

 -  The Journal of dermatological treatment  2009 
 - 132-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1471-1753 
<br/><br/><label>Standard No.: </label>10.1080/09546630902984596  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adverse Drug Reaction Reporting Systems<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Canada<br/>Drug and Narcotic Control<br/>Drug-Related Side Effects and Adverse Reactions<br/>Europe<br/>Female<br/>Humans<br/>Leukoencephalopathy, Progressive Multifocal--chemically induced<br/>Male<br/>Psoriasis--drug therapy<br/>Risk Assessment<br/>United States<br/>Withholding Treatment